Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04467203Phase 1Completed
Phase 1, randomised, open-label trial of Fadanafil in erectile dysfunction (ED) (2 arms), sponsored by Sihuan Pharmaceutical. Primary endpoint: Pharmacokinetic Parameter AUC(0-24) at 36 hours. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04467203.